öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º¹ùì¿
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º52

ËùÊôԺУ£ººÓ±±Ò½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×Áöѧ


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºguowei7303@163.com


¸öÈ˼òÊö :
³¤ÆÚÒÔÀ´Ò»Ö±ÖÂÁ¦ÓÚʳ¹Ü°©¡¢êÚÃÅ°©µÈºÓ±±Ê¡¸ß·¢Ö×ÁöµÄ·Ö×Ó²¡ÒòѧÑо¿£¬Ö÷ÒªÑо¿·½ÏòΪÖ×ÁöµÄ·Ö×ÓÒÅ´«Ñ§¼°±í¹ÛÒÅ´«Ñ§Ñо¿¡£Ñо¿Ö×ÁöÏà¹Ø»ùÒòµ¥ºËÜÕËá¶à̬ÐÔÓëʳ¹Ü°©¡¢êÚÃÅ°©µÈÖ×ÁöµÄ·¢²¡·çÏÕ¼°¼²²¡½øÕ¹µÄ¹Øϵ£»¶Ôʳ¹Ü°©¡¢êÚÃÅ°©¼°°©Ç°²¡±ä×éÖ¯¼°Ñ­»·DNAÖÐÖ×ÁöÏà¹Ø»ùÒòµÄ±íÒÅ´«Ñ§Ê§»î»úÖÆÈç¼×»ù»¯×´Ì¬¡¢×éµ°°×ÒÒõ£»¯µÈ½øÐÐÁËÉîÈëµØÑо¿£»¶Ô·Ç±àÂëRNAÈçmicroRNAºÍlncRNAÔÚʳ¹Ü°©¡¢êÚÃÅ°©·¢Éú·¢Õ¹ÖеÄ×÷ÓýøÐÐÁËϵÁÐÑо¿£»²¢¶Ôʳ¹Ü°©êÚÃÅ°©·¢Éú·¢Õ¹¹ý³ÌÖÐÖØÒªÐźÅתµ¼Í¨Â·ÈçTGF-¦Â/Smadsͨ·µÈ½øÐÐÁËϵͳÑо¿¡£Ôø×÷ΪÖ÷ÒªÈËÔ±²ÎÓë¡°¼Ò×å¾Û¼¯ÐÔʳ¹Ü°©ºòÑ¡»ùÒò¶à̬ÐÔÑо¿¡±µÄ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¿ÎÌâ¡¢¡°¼Ò×å¾Û¼¯ÐÔºÍÉ¢·¢ÐÔʳ¹Ü°©µÄÊÕ¼¯¼°Ïà¹Ø»ùÒòµÄÑо¿¡±µÄ¹ú¼Ò¡°863¡±¿ÎÌâ¡£×÷ΪµÚÒ»Ö÷ÑÐÈËÏȺó³Ðµ£ÁË¡°Ê³¹Ü°©ÖÐRASSF1A»ùÒò¹Ø¼üÐÔCpGλµãÒì³£¼×»ù»¯µ¼Ö»ùÒòʧ»îµÄ·Ö×Ó»úÖÆ¡±¼°¡°³¤Á´·Ç±àÂëRNA AC074286.1ÔÚʳ¹ÜÁÛ°©ÖеÄÉúÎïѧ¹¦Äܼ°Æä±í¹ÛÒÅ´«»úÖÆ¡±µÄ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¡¢¡°³¤Á´·Ç±àÂëRNA XLOC_002319ÔÚʳ¹ÜÁÛ°©ÖеÄÉúÎïѧ×÷Óü°±í¹ÛÒÅ´«Ñ§»úÖÆ¡±µÄºÓ±±Ê¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿ÒÔ¼°Öйú²©Ê¿ºó¿Æѧ»ù½ðÒ»µÈ×ÊÖúÏîÄ¿¡£ÔÚ¹ú¼ÊÆÚ¿¯ÒÔµÚÒ»×÷Õß¼°Í¨Ñ¶×÷Õß·¢±íSCIÂÛÎÄ30Óàƪ£¬×î¸ßÓ°ÏìÒò×ÓΪ6.198£¬ÀÛ¼ÆÓ°ÏìÒò×Ó´ï80ÒÔÉÏ£¬ÔÚ¹úÄÚºËÐÄÆÚ¿¯ÒÔµÚÒ»×÷Õß¼°Í¨Ñ¶×÷Õß·¢±íÂÛÎÄ30Óàƪ£¬ÔøÒÔÖ÷ÒªÍê³ÉÈË»ñºÓ±±Ê¡¿Æ¼¼½ø²½¶þµÈ½±Ò»ÏºÓ±±Ê¡¿Æ¼¼½ø²½ÈýµÈ½±ÈýÏºÓ±±Ê¡Ò½Ñ§»áÒ»µÈ½±ÁùÏî¡£

¿ÆÑй¤×÷ :
1. Guo W, Cui L, Wang C, Guo Y, Shen S, Kuang G, Dong Z. Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma. Clin Exp Metastasis. 2014 31(5):521-533.2. Guo W, Zhang M, Shen S, Guo Y, Kuang G, Yang Z, Dong Z. Aberrant methylation and decreased expression of the TGF-¦Â/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Cancer. 2014 120(16):2412-2423. 3. Guo W, Wang C, Guo Y, Shen S, Guo X, Kuang G, Dong Z. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. Clin Exp Metastasis. 2015 32(1):83-98.4. Han L, Dong Z, Wang C, Guo Y, Shen S, Kuang G, Guo W. Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma. Mol Carcinog. 2015 54(12):1722-1733. £¨Í¨Ñ¶×÷Õߣ©5. Guo W, Dong Z, Bai Y, Guo Y, Shen S, Kuang G, Xu J. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. Tumour Biol. 2015 36(4):2845-2854.6. Guo W, Zhang M, Guo Y, Shen S, Guo X, Dong Z. FBXO32, a new TGF-¦Â/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma. Neoplasma. 2015 62(4):646-657. 7. Guo W, Dong Z, Guo Y, Shen S, Guo X, Kuang G, Yang Z. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. Mol Carcinog. 2016 55(11): 1655-1666. 8. Guo W, Dong Z, Cui J, Guo Y, Shen S, Guo X, Kuang G. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma. Clin Exp Metastasis. 2016 33(1): 73-85.9. Liu Y, Dong Z, Liang J, Guo Y, Guo X, Shen S, Kuang G, Guo W. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Tumour Biol. 2016 37(4):5621-5632. £¨Í¨Ñ¶×÷Õߣ©10. Guo W, Dong Z, Shi Y, Liu S, Liang J, Guo Y, Guo X, Shen S, Wang G. Methylation-mediated downregulation of long noncoding RNA LOC** in gastric cardia adenocarcinoma. Clin Exp Metastasis. 2016 33(5):497-508.